HLA-B27 Subtypes in Japanese with seronegative spondyloarthropathies and healthy controls

Journal of Rheumatology

Volumn 23, Issue 7, 1996, Pages 1189-1193

  Yamaguchi, Akihiro ^a,b,c,d   Ogawa, Atsuko ^a,d   Tsuchiya, Naoyuki ^a   Shiota, Michiko ^a,d   Mitsui, Hiroshi ^a,b   Tokunaga, Katsushi ^c,d   Tadokoro, Kenji ^b,d   Juji, Takeo ^a,d   Ito, Koji ^a,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b MITSUI MEMORIAL HOSPITAL   (Japan)

^c Japanese Red Cross Central Blood Center

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

HLA B27 SUBTYPE; JAPANESE; SPONDYLOARTHROPATHY

Indexed keywords

HLA B27 ANTIGEN; OLIGONUCLEOTIDE;

ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA DETERMINATION; DNA HYBRIDIZATION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; HUMAN; JAPAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; REITER SYNDROME; SINGLE STRAND CONFORMATION POLYMORPHISM; SPONDYLOARTHROPATHY;

ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CONSENSUS SEQUENCE; HISTOCOMPATIBILITY TESTING; HLA-B27 ANTIGEN; HUMANS; IMMUNOBLOTTING; JAPAN; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE ANALYSIS, DNA; SPONDYLITIS, ANKYLOSING;

EID: 0029680126     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Hammer RE, Maika SD, Richardson JA, Tang IP, Taurog JD: Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human 2m: An animal model of HLA-B27associated human disorders. Cell /990;63:1099-112.
2. Rubin LA, Amos CI, Wade JA, et al: Investigating the genetic basis for ankylosing spondylitis. Linkage studies with the major histocompatibility complex region. Arthritis Rheum 7994;37:1212-20.
3. Khan MA: HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol 7995;7:263-9.
4. Lopez-Larrea C, Sujirachato K, Mehra NK, et al: HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Evidence for new associations. Tissue Antigens /995;45:169-76.
5. Yamaguchi A, Tsuchiya N, Mitsui H, et ai. Association of HLA-B39 with HLA-B27 negative ankylosing spondylitis and pauciarticular juvenile rheumatoid arthritis in Japanese patients. Evidence for the role of the peptide-anchoring B pocket. Arthritis Rheum /995;38:1672-7.
6. Islam SMM, Masuda K, Maeda H, Matsuki K, Fujino Y, Numaga J: Molecular subtypes of HLA-B27 in acute anterior uveitis associated with ankylosing spondylitis. 27th International Congress of Ophthalmology, Toronto, 1994; 159.
7. van der Linden S, Valkenburg HA, Cats A: Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984; 27:361-8.
8. Wilkens RF, Arnett FC, Bitter T, Calin A, Fisher L: Reiter's syndrome: Evaluation of preliminary criteria for definite disease. Arthritis Rheum /9S/;24:844-9.
9. Lin L, Tokunaga K, Ishikawa Y, et al: Sequence analysis of serological HLA-A11 split antigens, A 11.1 andA11.2. Tissue Antigens /994;43:78-82.
10. Dominguez O, Goto E, Martinez-Naves E, Choo SY, Lopez-Larrea C: Molecular typing of HLA-B27 alleles. Immunogenetics ;992;36:277-82.
11. Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Greenwood BM, McMichael AJ: HLA class I typing by PCR: HLA-B27 and an African B27 subtype. Lancet /99/;337:640-2.
12. Breur-Vriesendorp BS, Dekker-Saeys AJ, Ivanyi P: Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: The disease is associated with a common determinant of the various B27 molecules. Ann Rheum Dis /9S7;46:353-6.
13. Saitou N, Tokunaga K, Omoto K: Genetic affinities of human populations. In: Roberts DF, Fujiki N, Torizuka K, eds. Isolation, Migration and Health, SSHB 33. Cambridge: Cambridge University Press, 1992:118-29.
14. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T: Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991, vol 1: Oxford: Oxford University Press, 1992:1065-220.
15. Colbert RA, Rowland-Jones SL, McMichael AJ, Frelinger JA: Differences in peptide presentation between B27 subtypes: The importance of the PI side chain in maintaining high affinity peptide binding to B 2703. Immunity /994/1:121-30.
16. Falk K, Rötzschke O, Takiguchi M, et al: Peptide motifs of HLAB38 and B39 molecules. Immunogenetics /995,-41:162-4.
17. Feltkamp TEW, Khan MA, Lopez de Castro JA: The pathogenic role of HLA-B27. Immunol Today 1996; 17:5-7.